Jackson Acquisition Company II (JACS) Technical Analysis & Indicators

Jackson Acquisition Company II (JACS) — Price $10.79 Financial ServicesShell Companies — NYSE

Latest reported results:

Technical analysis of Jackson Acquisition Company II (JACS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Jackson Acquisition Co. II operates as a special purpose acquisition company (SPAC). Its primary objective is to pursue a business combination, which could involve a merger, capital stock exchange, asset acquisition, stock purchase, or reorganization, with one or more operating entities. This company was established on September 11, 2024, and maintains its principal offices in Alpharetta, GA.

Price Performance

1 month+0.75%
3 months+1.31%
Year-to-date+3.55%
1 year+4.15%

52-Week Range

52-week High$10.79
52-week Low$10.33
Avg Volume (90d)42K

Technical Indicators

SMA 50$10.72
SMA 200$10.58
Beta0.00
30-day Volatility (annualised)2.2%
Price vs SMA 50+0.7%
Price vs SMA 200+2.0%

Monthly Close (12 months)

MonthCloseChange
2025-10$10.45
2025-11$10.41-0.4%
2025-12$10.42+0.1%
2026-01$10.48+0.6%
2026-02$10.51+0.3%
2026-03$10.59+0.8%
2026-04$10.60+0.1%
2026-05$10.62+0.2%
2026-06$10.64+0.2%
2026-07$10.70+0.6%
2026-08$10.74+0.4%
2026-09$10.79+0.5%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-09-14$-2.53
2026-09-14$159M
2026-09-14$-0.26$14M
2026-09-14
2026-09-14$0.84$26M
2026-09-14

Price

Price$10.79
Market Cap$319M
ExchangeNYSE
CountryUS

Valuation Ratios

P/E Ratio36.35
Price / Book1.00
EV / EBITDA-540.47
Dividend Yield0.00%

Financial Health

Debt / Equity0.00
Current Ratio0.77

Related companies: ALDF · ATII · GRAF · LOKV · NPAC · OBA · POLE

Explore sector: Financial Services · Shell Companies

More sections of JACS: Overview · Financials · Valuation · Statistics · Estimates · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks